chr22-20991686-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP3PS3_ModeratePM2_SupportingPS4_SupportingPS2
This summary comes from the ClinGen Evidence Repository: The NM_006767.4:c.850C>T variant in LZTR1 is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 284 (p.Arg284Cys). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.801, which is above the threshold of 0.7, evidence that correlates with impact to LZTR1 function (PP3). This variant has been reported in 1 proband meeting NS diagnostic criteria (PS4_Supporting; PMID:25795793). This variant has been identified as a de novo occurrence with confirmed parental relationships in 1 individual with Noonan syndrome (PS2; PMID:25795793). RAS, MEK, and ERK activation in HEK293T cells showed increased level of endogenous active, GTP-bound RAS and increased phosphorylation of MEK and ERK, indicating that this variant impacts protein function (PMID:30481304)(PS3_Moderate). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: PS2, PS3_Moderate, PS4_Supporting, PM2_Supporting, PP3. (ClinGen RASopathy VCEP specifications version 1.3; 12/3/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA204980/MONDO:0021060/094
Frequency
Consequence
NM_006767.4 missense
Scores
Clinical Significance
Conservation
Publications
- LZTR1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Noonan syndrome 10Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- schwannomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Noonan syndromeInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
- Costello syndromeInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- cardiofaciocutaneous syndromeInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome-like disorder with loose anagen hairInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | MANE Select | c.850C>T | p.Arg284Cys | missense | Exon 9 of 21 | ENSP00000496779.1 | Q8N653 | ||
| LZTR1 | c.850C>T | p.Arg284Cys | missense | Exon 9 of 21 | ENSP00000558088.1 | ||||
| LZTR1 | c.850C>T | p.Arg284Cys | missense | Exon 9 of 21 | ENSP00000558091.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 230910 AF XY: 0.00
GnomAD4 exome AF: 0.00000689 AC: 10AN: 1451524Hom.: 0 Cov.: 31 AF XY: 0.00000832 AC XY: 6AN XY: 721506 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74330 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at